Generic Name and Formulations:
Oxybutynin chloride 3% (delivering 28mg per pump actuation); topical gel; contains alcohol.
Company:
Actavis
Overactive bladder (OAB) with urge urinary incontinence, urgency, and frequency.
Apply three pumps (84mg) once daily to dry, intact skin on abdomen, upper arm/shoulders, or thighs. Rotate application sites; avoid use of same site on consecutive days. Wash hands after application. Avoid washing area/showering for 1 hour after application.
Not recommended.
Antispasmodic/anticholinergic.
Urinary or gastric retention. Uncontrolled narrow angle glaucoma.
Bladder outflow obstruction. Gastrointestinal obstruction. Decreased GI motility. Ulcerative colitis. Intestinal antony. Gastroesophageal reflux. Esophagitis. Hepatic or renal dysfunction. Myasthenia gravis. Controlled narrow angle glaucoma. Discontinue if skin hypersensitivity or angioedema develops; consider discontinuing if anticholineric CNS effects occur. Skin transference: cover application site with clothing after gel has dried if direct contact is anticipated. Exposure to high environmental temperatures. Gel is flammable. Pregnancy (Cat.B). Nursing mothers.
Caution with drugs that can cause or exacerbate esophagitis (eg, bisphosphonates). Additive effects with other anticholinergics.
Dry mouth, application site reactions (eg, pruritus, dermatitis), urinary tract infection, dizziness, nasopharyngitis, fatigue, headache, constipation, other anticholinergic effects (eg, CNS).
Gel (1 gram/sachet)—30; Gel 3% pump—92g